Avoid · 38/100 · high confidence

LiveRamp Holdings, Inc. (RAMP) — Council Assessment

🔴 AVOID · Score 38/100 · high confidence

RAMP is no longer a standalone investment — it's a merger-arb trade at $37.70 vs. a $38.50 Publicis cash offer, with ~2% upside capped and 20-30% downside if the deal breaks.

As of 2026-06-28. 18 lenses weighed in, 0 abstained. Sources: 6 filings, 15 news, 15 discussion, 1 earnings_call.

360 narrative — news & sentiment digest

LiveRamp Holdings (RAMP) — Investment Briefing

⚠️ Material Development: Acquisition Announced

Publicis announced acquisition of LiveRamp for $38.50/share (~$2.2–2.5B cash deal), announced mid-May 2026. Stock surged 27% on announcement. Deal pending regulatory and shareholder approval; completion timeline uncertain. This fundamentally changes the investment thesis—RAMP is no longer a standalone growth story but an arbitrage/M&A event with regulatory and execution risk.

Management Commentary (Q2 FY2026 Earnings Call, 15 Nov 2025)

Overall Tone: Confident, execution-focused; management emphasizes momentum despite modest near-term growth rates.

Revenue & Growth Drivers

Q2 revenue: $200M (+8% YoY), beat guidance by $3M.
Subscription revenue: $150M (+5% YoY)—"low watermark" inflection; CFO Lauren Dillard called it the trough.
Net new ARR: $14M organic increase (best in 7 quarters); ARR up 7% YoY.
Marketplace & other: $50M (+18% YoY); Data Marketplace +14%, driven by CTV integrations and stable ad spending.

Key Momentum Indicators

Million-dollar-plus customers: +5 sequentially to 132 (new high).
New logo wins: Auto manufacturer (multimillion-dollar), social media platform (upsell).
Subscription net retention: 102% (at target band of 100–105%).

Strategic Initiatives

1. Commerce Media & CTV

Expanding beyond retail to new verticals: Uber, PayPal, GM, United Airlines powering merchant networks.
Netflix partnership expanded to 10 new international markets.
Clean room solutions driving cross-sell in retail media networks (Albertsons, Target Roundel).

2. AI Integration (Six Partnership Categories)

Audience segment builder (natural-language-driven); agentic orchestration.
Partnerships with Perplexity, Dappier, and others across search, commerce, creative, measurement.
Management positioned AI as a catalyst: "AI models are only as effective as the signals that power them"—first/second-party data is the differentiator.

3. Usage-Based Pricing Model (Pilot Phase)

July–March pilot: "Overwhelmingly positive" feedback; opportunistically expanding beyond initial target.
Land motion: Lower entry point for mid-size brands, media platforms, data providers.
Expand motion: Fungible tokens valid across 12 months; customers can explore features at no extra cost.
Customer examples: Beverage company (5-figure → 6-figure ACV potential); airline (existing 7-figure customer, 20% upsell on early renewal).
Guidance caveat: No upside baked into FY26 guidance; roll-out expected early FY27, benefit accrual over several quarters.

Profitability & Capital Allocation

Non-GAAP operating income: +10% YoY to $45M; margin 22.3% (up from prior guidance).
GAAP operating income: +127% YoY; margin expanded 7 points to record quarterly high.
Stock-based comp: -23% YoY (disciplined approach).
Cost efficiencies: Offshore operations in India driving OpEx leverage; platform modernization ongoing (migration to new backend completing Q4).
Free cash flow: $57M in Q2; $80M YTD repurchases; $177M remaining authorization (expires Dec 31, 2026).
Balance sheet: $377M cash/ST investments; zero debt.

Guidance Updates (FY26)

Revenue: $804–818M (+8–10% YoY); raised from prior guide.
Subscription revenue: Mid–high single digits.
Marketplace & other: Mid-team growth.
Gross margin: ~72% (revised down; platform migration delaying cost optimization into Q4).
Non-GAAP operating income: $178–182M (+3% midpoint); margin 22% (+4 points).
GAAP operating margin: Record 10–11% (+9–10 points YoY).
Q3 guidance: $209–213M revenue; $55–57M non-GAAP OpInc; 27% margin.

Rule of 40 Ambition

FY26 midpoint: Rule of 31 (9% growth + 22% margin).
FY28 target: Rule of 40 (10%+ growth + 30% margin).
Management expressed confidence: "Costs are highly fixed…ongoing cost efficiencies from offshoring."

Notable Q&A Exchanges

Q: Open web shift & AI search impact?

A (Scott Howe, CEO): Exposure to open web is low. Top 20 destinations (Meta, Roku, Disney+, Pandora, X, TikTok) largely unaffected. Upside from AI high: first/second-party data is the differentiator for AI model performance.

Q: Macro conservatism in guidance?

A (Lauren Dillard, CFO): Appropriate level of conservatism baked in. Low-end assumes major macro deterioration; midpoint assumes stable environment. Variable revenue (usage, marketplace) drives swing factors.

Q: Pricing pilot upside not in guidance?

A (Dillard): Correct; no benefit accrued to FY26 guidance. Pilot runs through fiscal year-end; fine-tuning expected; roll-out in early FY27; benefit accrual over several quarters.

Recent Developments

May 18–19, 2026: Publicis acquisition announced at $38.50/share; stock surged 27% to approach 52-week highs.
June 23–25, 2026: Form 4 filings (CRO RSU withholding); law firm investigating merger fairness (routine post-deal filings).
Mid-2026: Ongoing pilot of usage-based pricing model; backend platform migration completing Q4 FY26.
Adobe partnership: Joint integration of purchase data with AI ads for commerce networks (mentioned in news).

Bull Narrative

ARR inflection evident: Net new ARR of $14M is the best in 7 quarters; 7% YoY growth and million-dollar-plus customer count at record high suggest the trough has passed. Management's comments on "accelerating topline growth in FY27" align with sales momentum.
Strategic positioning in AI-driven advertising: Commerce media, CTV, and AI partnerships address structural tailwinds in the ad-tech ecosystem. Clean room solutions and first/second-party data moats are defensible as third-party cookies fade and AI models require high-quality signals.
Usage-based pricing model de-risks land and expand: Early pilot feedback described as "overwhelmingly positive." Fungibility and lower entry point broaden TAM. If adoption accelerates in FY27, could drive incremental revenue growth that management has not yet reflected in guidance.
Margin expansion runway: Offshoring savings and platform modernization are ongoing. Management targets Rule of 40 by FY28 (10%+ growth + 30% margin); current trajectory (9% + 22%) shows clear path if revenue growth re-accelerates.
Strong free cash flow & shareholder returns: $57M FCF in Q2, $80M YTD buybacks, $177M authorization remaining. Management confidence in capital allocation despite acquisition event signals conviction in business model.
New logo wins and customer quality: Wins from auto OEMs, social media platforms, airlines, beverage firms show broad-based demand across verticals beyond traditional retail media.

Bear Narrative

Organic subscription growth stalled: Fixed subscription revenue +6% YoY; usage down slightly. Even though ARR is inflecting, subscription revenue growth remains in mid-single digits—well below historical norms for a SaaS platform. Investors betting on re-acceleration may face disappointment if macro deteriorates or customer churn resurfaces.
Pricing pilot unproven at scale: Management explicitly stated no upside baked into FY26 guidance. Roll-out in early FY27; benefits accrue over "several quarters." This is forward-guidance hedging. If adoption is slower than expected or cannibalization occurs (existing customers migrate to lower ACV model), guidance could be at risk.
Platform migration overhead drag: Gross margin compressed 3 points YoY due to cloud hosting costs and dual platform support. While CFO said optimization is "taking longer than expected," Q4 completion is promised. If delays extend into FY27, margin expansion may stall.
Macro stability assumption fragile: Management acknowledges "conservative" guidance includes midpoint assumption of stable macro. Wide FY26 revenue range ($804–818M) reflects low-end macro deterioration scenario. Retail/CPG ad spending slowdown would hit both subscription and marketplace revenue.
Acquisition overhang & regulatory risk: Deal announced at $38.50/share; stock trading near that price suggests market assigns material deal risk (regulatory delays, termination). Management commentary on standalone performance is now overshadowed by M&A uncertainty; business disruption, talent/customer loss, and potential deal failure are real risks highlighted in 10-K.
Limited visibility on AI monetization: While AI partnerships and capabilities are hyped, management has not quantified incremental revenue or margin impact. Integrations with Perplexity, Dappier, etc., are in early stages. AI could be a competitive moat or a commodity; too early to assign significant financial weight.

Retail Sentiment

Tone: Mixed, with deal-driven arbitrage replacing fundamental debate.

Pre-acquisition (through May 18): Some retail optimism on ARR inflection, usage-based pricing pilot, and AI positioning. A few retail investors highlighted potential undervaluation and AI upside (e.g., "40% undervalued as AI marketing demand grows").
Post-acquisition (May 18 onwards): Sentiment shifted to deal mechanics. Retail noted 27% pop on announcement; some celebrated gains and sold ("Sold all, very good gain"). Others flagged arbitrage spreads: stock trading $37.70–$38.50 vs. deal price of $38.50, indicating modest deal risk perception.
Law firm investigation (filed within hours of deal): Routine post-M&A behavior; retail noted this as "clockwork" and called it a non-event.
Deal confidence: One retail commenter dismissed arbitrage skepticism: "$100 confirmed deal…who, why, and how can derail this?" Suggests moderate conviction deal will close.

Overall, retail conversation has moved away from fundamental operating metrics and toward deal arbitrage and M&A risk. Pre-deal optimism on AI and pricing model remains but is now subordinated to deal closure timeline.

Caveats

Acquisition overhang dominates: The $38.50/share deal announced mid-May fundamentally shifts the investment case. Standalone performance commentary from the November earnings call is now historical. Regulatory approvals (antitrust, shareholder vote) remain pending; deal could be delayed or terminated. Stock is trading as an M&A arbitrage, not a standalone growth story.
Management guidance conservatism: CFO explicitly stated no upside from pricing pilot in FY26 guidance. This is standard de-risking language, but it also suggests management confidence in upside is moderate. ARR inflection is real but still single-digit YoY (7%); not explosive.
Platform migration execution risk: Dual-platform overhead is dragging gross margin. While Q4 completion is promised, history of IT modernizations shows delays are common. If margins don't rebound as expected, FY27 profitability guidance could slip.
AI monetization remains speculative: Partnerships are announced, but revenue attribution and scaling are not yet clear. Management has not quantified AI-driven incremental revenue or provided customer examples of AI-driven upsells. This is a strategic bet, not a proven revenue driver yet.
Thin/low-quality post-deal coverage: Most recent news items are M&A-focused or technical (valuation, technical analysis). Substantive earnings or business analysis pieces are sparse. Retail chatter has shifted away from fundamentals.
Retail sentiment data limited: Forum discussion is sparse and dominated by deal arbitrage commentary. Limited visibility into institutional or sell-

Bull case

The underlying business genuinely improved: FY2025 net income of $146M after years of losses, FCF of $149M at 18.3% margin, near-perfect cash conversion, capital-light model (capex $1.4M), and a clean net-cash balance sheet (~$141M net cash, current ratio 2.7). The moat is real — RampID identity graph, clean-room network effects, high switching costs — and the AI/disruption referee (PASS 72) and forensic short-seller (PASS 62) both see durable infrastructure value. Standalone DCF of $49.52 implies the business is worth well above the $38.50 deal price, meaning Publicis is arguably buying at a discount. If the deal breaks AND the standalone story re-accelerates toward Rule-of-40, patient owners could capture that gap.

Bear case

The stock is capped at the $38.50 deal price with only a ~$0.80 (2.1%) spread left. Asymmetry is inverted: ~2% upside if the deal closes vs. 20-30% downside to pre-announcement ~$28-30 if regulatory/shareholder approval fails. There is no margin of safety at current price. Standalone quality is also sub-par for most schools: ROIC of 5.4% sits well below WACC (~10.1%), meaning growth is currently value-destructive; subscription growth is stuck mid-single-digits; earnings history is erratic (losses FY21/FY22/FY24, sudden $146M profit FY25 that is unexplained); and 73% of DCF value is terminal value. The improving-fundamentals story is real but unproven across a cycle — and irrelevant while the deal caps the tape.

Dissent — where the council disagrees

The sharpest disagreement is between the deal-mechanics camp and the franchise-quality camp. Klarman, Druckenmiller, and Schloss (all AVOID, 22-28) argue the risk/reward is emphatically negative — picking up pennies in front of a steamroller. Against them, the AI/Disruption referee (PASS 72) and the Forensic Short-Seller (PASS 62) see a durable, cleanly-accounted data-infrastructure moat that a sophisticated buyer is paying a control premium for. The valuation referee and every quality lens (Buffett, Munger, Akre, Smith, Mauboussin) land in the middle (WATCH 52-58) but converge on one damning number: ROIC of 5.4% is far below the 15-20% they demand and below WACC — the moat is real but not yet monetized into economic profit. The tension that resolves this to Avoid: even the standalone bulls concede the thesis is inaccessible while the deal caps upside, and the standalone quality doesn't clear the bar to justify holding through deal-break downside.

Key risks

Deal-break risk: regulatory or shareholder rejection sends stock to pre-announcement ~$28-30, a 20-30% loss vs. ~2% upside
ROIC (5.4%) below WACC (10.1%) — growth is value-destructive until margins expand to ~30% non-GAAP, which is unproven execution
Erratic/unexplained earnings: FY25's $146M profit after years of losses may embed non-recurring items (tax benefit, deferred revenue) not verifiable in truncated filings
73% of DCF value in terminal value — highly sensitive to WACC and terminal-growth assumptions
Secular TAM compression from hyperscaler walled gardens (Google/Meta/Amazon) and probabilistic AI targeting bypassing identity resolution
Data-quality issues in the fact base (OCF dated 2013, LT debt 2015, liabilities 2019) obscure the true current balance sheet

Catalysts

Publicis deal close at $38.50 (~2% gross return) — base case ~80% probability
Regulatory approval milestones or a competing/bump bid (no current evidence of the latter)
Deal termination — negative catalyst that would reprice shares 20-30% lower but re-open a standalone entry
Usage-based pricing rollout and AI-monetization traction in FY27 (relevant only in a deal-break scenario)
Rule-of-40 progress / margin expansion as platform migration completes

DCF valuation (finance-expert model)

two-stage DCF, Gordon terminal value, CAPM-weighted WACC.

Intrinsic value: $49.52/share vs price $37.7 → +31% (bear $40.64 · base $49.52 · bull $59.53).

Step	Value
Base free cash flow	$149M
FCF growth (yrs 1-5)	10.9% (revenue CAGR)
WACC (β 1.275)	10.1%
Terminal growth	2.5%
PV of explicit FCF	$759M
PV of terminal (residual) value	$2.1B (73% of EV)
Enterprise value	$2.8B
less Net debt	$-141M
= Equity value	$3.0B
/ Shares (60M) = intrinsic/share	$49.52

Short-sell evaluation

🚫 AVOID SHORTING

Shorting RAMP is a bad idea despite sub-WACC returns and a rich price-to-EPV, because the stock is pinned to a $38.50 all-cash Publicis offer — the single worst setup for a short. Your downside is a bump bid or firm deal support (unlimited/asymmetric loss to the upside), while your best case is a deal break that only takes the stock to ~$28-30, and even that requires timing a binary regulatory/shareholder event. The forensic picture is clean (FCF and OCF both exceed net income, negative accrual ratio, net-cash balance sheet), removing the accounting-fraud angle a Chanos/Einhorn short would need. There is no promotional bubble here; if anything the acquirer is paying below DCF intrinsic value. This is a merger-arb instrument, not a short candidate.

Pros (the short could work)

ROIC (5.4%) below WACC (10.1%) — growth is currently value-destructive
EPV-based fair value (~$27/share on FCF basis) is well below the $37.70 price; buyers pay entirely for growth
Subscription growth stuck at mid-single digits; secular walled-garden and AI-targeting threats to the identity-resolution TAM
73% of value in terminal value — fragile to any WACC/growth disappointment
Unexplained FY25 profit reversal raises earnings-quality questions if the deal breaks and the standalone story is tested

Cons (what kills the short)

Pinned to a $38.50 all-cash deal — a bump bid or deal support means immediate, asymmetric loss on the short
Clean forensics: FCF ($149M) and OCF ($150M) both exceed net income; negative accrual ratio, no fraud angle
Net-cash balance sheet (~$141M net cash), 2.7x current ratio, minimal capex — no financial-distress catalyst
Active buybacks ($80M YTD) and declining SBC support the share price
Deal-break downside only to ~$28-30 (~20-30%), a modest and event-dependent payoff against unlimited upside risk
A sophisticated strategic buyer is paying a control premium at a discount to DCF — validates, not undermines, the value

Council scorecard

Lens	School	Stance	Score	Conf
AI & Disruption Referee (Christensen-style)	referee	🟢 pass	72	medium
Forensic Short-Seller (Chanos/Einhorn-style)	referee	🟢 pass	62	medium
Valuation Referee (Damodaran-style)	referee	🟡 watch	58	medium
Bruce Greenwald	value	🟡 watch	58	medium
Terry Smith (Fundsmith)	quality	🟡 watch	58	medium
Michael Mauboussin	quality	🟡 watch	58	medium
Chuck Akre	quality	🟡 watch	55	medium
Joel Greenblatt	value	🟡 watch	55	medium
Warren Buffett	quality	🟡 watch	52	medium
Ray Dalio	risk	🟡 watch	52	medium
Philip Fisher	growth	🟡 watch	52	medium
Peter Lynch	growth	🟡 watch	52	medium
Howard Marks	risk	🟡 watch	52	high
Charlie Munger	quality	🟡 watch	52	medium
Benjamin Graham	value	🟡 watch	48	medium
Stanley Druckenmiller	risk	🔴 avoid	28	high
Seth Klarman	value	🔴 avoid	28	high
Walter Schloss	value	🔴 avoid	22	high

Member reasoning

AI & Disruption Referee (Christensen-style) — 🟢 pass · 72/100 · medium confidence

LiveRamp occupies a genuinely interesting position in the AI disruption framework: it is simultaneously an intermediary (a potential disintermediation target) AND a proprietary data-infrastructure layer that AI models need to function well in advertising. The Christensen test here is nuanced. The core job LiveRamp does is identity resolution — stitching together first-party data from disparate sources so that advertisers can activate audiences, measure attribution, and collaborate across clean rooms without sharing raw PII. The question is whether AI makes this function obsolete or more valuable. My assessment: the balance tilts modestly toward more valuable, but with real risk embedded in the intermediary role. The identity graph and clean-room infrastructure are genuinely scarce. A frontier LLM cannot replicate LiveRamp's cross-publisher, cross-device identity spine from scratch — the moat is not an algorithm but a network of data-sharing agreements, regulatory-compliant infrastructure, and embedded integrations with publishers, retailers, and platforms. This is closer to a toll-road than a matching algorithm; it is hard to reproduce because it requires bilateral agreements at scale, not just compute. However, the disintermediation risk is real on two vectors: (1) hyperscalers (Google Privacy Sandbox, Meta's on-platform targeting, Amazon DSP) increasingly offer walled-garden alternatives that bypass third-party identity resolution entirely, reducing the surface area where LiveRamp adds value; and (2) AI-native ad targeting (using contextual signals, behavioral inference, and LLM-generated audience proxies) could reduce advertisers' dependence on precise identity matching if 'good enough' probabilistic targeting becomes acceptable. Management's positioning — 'AI models are only as effective as the signals that power them; first/second-party data is the differentiator' — is directionally honest and not denial. The Adobe partnership tying purchase data to AI ad systems, and the Perplexity/Dappier integrations, show active embedding into the AI workflow stack rather than passive observation. The usage-based pricing pilot is a structural adaptation that broadens TAM rather than defending a contracting one. The acquisition by Publicis at $38.50/share is itself a strong signal: a major holding company is paying a control premium for LiveRamp's data infrastructure, precisely because it believes proprietary identity resolution and clean-room capabilities are durable and complementary to AI-driven campaign management. The bear case within this lens: if Google's Privacy Sandbox succeeds (or fails in a way that accelerates walled-garden dominance), if Meta and Amazon continue pulling spend on-platform, or if probabilistic AI targeting becomes 'good enough' for the long tail of advertisers, LiveRamp's subscription ARR could stagnate and the pricing power narrative collapses. The falsifiable call: disconfirmation would be visible as net revenue retention falling below 100%, take-rate compression on marketplace revenue, or accelerating customer concentration in the few remaining open-web publishers. Confirmation would be ARR re-acceleration above 10% in FY27 driven by AI-integration use cases and usage-based model adoption. Given the acquisition context, the standalone disruption risk is somewhat moot near-term, but as a framework assessment of the durable competitive position, the data-infrastructure layer scores better than a pure intermediary would.

Key points

Identity resolution and clean-room infrastructure require bilateral data-sharing agreements at scale — not replicable by a frontier model alone; the moat is network agreements, not just an algorithm
Management's framing ('AI models need first/second-party data signals') is directionally correct and not in denial — active AI partnerships (Adobe, Perplexity, Dappier) show embedding into the AI workflow stack
Publicis acquisition at control premium signals that a sophisticated, data-hungry buyer views LiveRamp's infrastructure as durable and complementary to AI-driven ad operations
Usage-based pricing pilot broadens TAM to mid-market and data providers — a structural adaptation rather than defensive contraction
Subscription net retention at 102% and million-dollar-plus customer count at record high (132) show no current commoditization signal in pricing or churn
Commerce media and CTV integrations (Netflix, Uber, PayPal, GM) diversify beyond open-web exposure, which is the most AI-disrupted segment of digital advertising

Red flags

Hyperscaler walled gardens (Google, Meta, Amazon) increasingly offer on-platform targeting that bypasses third-party identity resolution — structural TAM compression risk over 3-10 years
Probabilistic AI targeting using contextual/behavioral inference could reduce advertiser dependence on precise identity matching if 'good enough' thresholds shift downward
Open-web publisher ecosystem continues to shrink; if top-20 destinations (Meta, Roku, Disney+) internalize identity resolution, LiveRamp's middleware position erodes
AI-native ad-tech entrants (e.g., contextual-first DSPs) may undercut LiveRamp's pricing by offering audience activation without identity graph dependency
Platform migration overhead dragging gross margins suggests operational complexity that a leaner AI-native competitor would not carry
Management has not quantified incremental revenue from AI partnerships — framing is strategic positioning, not yet proven financial contribution

Forensic Short-Seller (Chanos/Einhorn-style) — 🟢 pass · 62/100 · medium confidence

LiveRamp presents a surprisingly clean forensic picture for a technology/SaaS company, but the acquisition context and several data inconsistencies in the fact base require careful parsing. The core Chanos test — earnings vs. cash divergence — actually resolves favorably here: reported FCF of $148.8M and operating cash flow of $150.1M comfortably exceed net income of $146M for FY2025, meaning cash conversion is solid and accruals are not inflating earnings. This is the opposite of a classic short setup. However, several forensic flags merit attention: (1) The fact base contains suspicious period mismatches — operating_cash_flow is dated '2013-03-31' and total_liabilities to '2019-03-31' and long_term_debt to '2015-03-31', suggesting either data errors or cherry-picked vintage figures that could obscure the true current balance sheet. (2) Net income swung wildly: losses of $34M, $119M, $1M in FY2021-2022-2024, then a sudden $146M profit in FY2025 — this discontinuity warrants scrutiny of what drove the profit reversal (tax benefits? asset sales? accounting changes?). (3) SBC: management explicitly called out SBC declining 23% YoY, but historical losses suggest heavy SBC was masking true economics for years. (4) The acquisition at $38.50/share vs. DCF intrinsic of $49.52 actually suggests the acquirer (Publicis) got a deal, not that the company was overvalued — reducing the typical 'story stock' short setup. (5) The $254M 'long_term_debt' flagged as dated 2015 is suspicious — if current debt is actually zero (as the Q2 earnings call implies, 'zero debt, $377M cash'), this is a data artifact, not a real liability. The kill question for a short would be: does the FY2025 profit reversal rest on non-recurring items (tax benefits, deferred revenue release) that will not repeat? The 10-K filing excerpt is too truncated to answer definitively. Given the acquisition at a modest premium to current price ($38.50 vs. $37.70), the real forensic question is deal risk, not accounting fraud. The company is not a compelling short on fundamentals — it is a merger arb situation with modest spread.

Key points

FCF ($148.8M) and operating cash flow ($150.1M) EXCEED net income ($146M) — opposite of classic short setup; accrual ratio is negative/clean
Net income reversal from multi-year losses to $146M profit in FY2025 requires explanation — tax benefits, deferred revenue, or accounting changes not visible in truncated 10-K
Fact base contains suspicious period mismatches (OCF dated 2013, LT debt dated 2015, total liabilities dated 2019) — data quality issue that obscures true balance sheet
Management confirmed 'zero debt, $377M cash' in Q2 earnings call, but fundamentals block shows $254M LT debt — irreconcilable without full 10-K review
SBC historically heavy (drove multi-year losses); management claims 23% YoY reduction, but share count at 60M needs multi-year trend to confirm dilution is not being masked by buybacks
Acquisition at $38.50 vs. DCF intrinsic $49.52 suggests modest premium — not a 'promotional bubble' scenario; acquirer Publicis appears to be buying at a discount to intrinsic value
Operating margin of 10.3% GAAP vs. 22% non-GAAP implies ~12 points of SBC and other add-backs — material but not extreme for SaaS; needs absolute dollar comparison

Red flags

FY2025 profit reversal ($146M net income after years of losses) is unexplained in available data — could be non-recurring tax benefit or deferred revenue release; truncated 10-K does not allow verification
Data period mismatches across key balance sheet items (OCF 2013, LT debt 2015, total liabilities 2019) suggest either data errors or that reported figures are vintage-mixed, making forensic balance sheet analysis unreliable
GAAP-to-non-GAAP gap of ~12 margin points suggests significant ongoing SBC add-back; SBC as percentage of non-GAAP 'profit' needs explicit dollar quantification which fact base lacks
Dual-platform migration overhead compressing gross margins (3 points YoY) — if delays extend, deferred cost recognition could mask deteriorating unit economics
Law firm investigation into merger fairness is routine but signals potential shareholder litigation risk that could delay or complicate deal closure
Insider activity: CRO RSU withholding (Form 4, June 23) is routine tax withholding, not discretionary selling — but cluster of Form 4s around deal announcement needs full review for any discretionary sales prior to announcement

Valuation Referee (Damodaran-style) — 🟡 watch · 58/100 · medium confidence

LiveRamp is a data connectivity/clean-room SaaS platform with a pending acquisition by Publicis at $38.50/share. The standalone DCF yields an intrinsic value of ~$49.52 (base), implying 31% upside to the current $37.70 price—but this analysis is now almost entirely academic because the stock is effectively a merger arbitrage instrument trading $0.80 below the deal price. As a Damodaran-style valuation exercise, I assess both the DCF quality and the deal-adjusted value. On the standalone DCF: the two-stage model uses FCF of ~$149M, 10.9% growth (proxied by 3-year revenue CAGR), WACC of 10.1%, and terminal growth of 2.5%. The terminal value represents 73% of enterprise value—a concern but not extreme for a growing software business. ROIC is 5.4% vs. WACC of 10.1%, meaning growth is currently value-destructive on an incremental basis, which is the central valuation red flag. However, FCF margin at 18.3% and operating margin at 10.3% suggest the business is genuinely generating cash and margins are expanding (GAAP operating margin reached record highs). The revenue CAGR of ~11% used for FCF growth is consistent with reported history ($529M→$813M over 4 years). The bear case DCF of $40.64 is essentially at-deal-price, meaning the standalone bear case and the deal price are nearly identical—a useful cross-check that suggests Publicis is not grossly overpaying nor paying a transformational premium. On deal-price analysis: stock at $37.70 vs. deal at $38.50 = 2.1% gross spread. At this spread the implied risk is modest; Johnson Fistel investigation is routine. The real risk is regulatory delay or termination ($32M termination fee is small relative to $2.2B deal). For a standalone investor, the DCF is credible but hinges on ROIC eventually crossing WACC as margins expand toward the Rule of 40 target (FY28: 10% growth + 30% margin). The 30% non-GAAP operating margin target vs. current 22% is achievable but not certain. The usage-based pricing pilot is unquantified. Debt-to-equity is low (0.26), balance sheet is strong ($396M cash), and CapEx is trivially low ($1.4M), suggesting capital-light model. The operating cash flow figure in the fact base ($150M) appears to reference a 2013 period—data quality caveat noted. FCF of $149M is used as base. The price-to-FCF of 15.4x and P/E of 15.7x are undemanding for a SaaS business with ~11% revenue growth—these multiples would be reasonable even on a standalone basis. However, the fact that ROIC (5.4%) sits well below WACC (10.1%) means the current growth rate is not creating value until margins improve materially. The DCF's implied expectations are not heroic—11% FCF growth for 5 years then stable 2.5%—and the bear case ($40.64) barely exceeds current price. This is a 'watch' rather than 'pass' because: (1) ROIC < WACC makes current growth value-destructive; (2) the stock is now a deal arb not a standalone story; (3) the margin-of-safety in the standalone DCF is modest (bear case ~$40.64 vs. $37.70 current, only 8% buffer); and (4) the terminal value at 73% of EV is sensitive to WACC assumptions. Not an 'avoid' because the deal provides a hard floor near current price, standalone FCF is real, and the DCF does not require heroic assumptions.

Key points

Standalone DCF base case $49.52 implies 31% upside, but deal at $38.50 makes this mostly academic—stock trades as merger arb at $37.70
Deal spread of only 2.1% ($37.70 vs $38.50) reflects low perceived deal risk; bear-case DCF of $40.64 nearly equals deal price, validating deal pricing as reasonable
ROIC of 5.4% is materially below WACC of 10.1%—current growth is value-destructive on incremental basis; value creation requires margin expansion to ~30% non-GAAP operating margin (FY28 target)
Revenue CAGR of 10.9% used in DCF is consistent with actual history ($529M in FY21 to $813M in FY26); growth assumption is not heroic
FCF of $149M at 18.3% margin with CapEx of only $1.4M confirms genuinely capital-light model; price-to-FCF of 15.4x is undemanding for the growth profile
Terminal value is 73% of EV—high but not extreme; terminal growth of 2.5% is at or below nominal GDP, which is appropriate
Balance sheet strong: $396M cash, D/E of 0.26, current ratio of 2.7; no financial distress risk
Usage-based pricing pilot and Rule of 40 FY28 target are unpriced options that would create value if delivered, but neither is in guidance or DCF

Red flags

ROIC (5.4%) < WACC (10.1%) means growth destroys value at current reinvestment efficiency; margin expansion to ~30% is required for growth to become value-accretive—this is execution risk, not certainty
Margin of safety on standalone basis is thin in bear case ($40.64 bear DCF vs. $37.70 price = only ~8% buffer); investment thesis depends on deal closing or margin expansion materializing
Operating cash flow data point in fact base references 2013 period—data quality flag; FCF figure used ($149M) appears internally consistent but cannot be fully verified from provided filings
Terminal value (73% of EV) is sensitive: a 100bps WACC increase would meaningfully reduce intrinsic value and could push base case toward deal price
Deal creates binary event risk: if Publicis deal fails (regulatory block, shareholder rejection), stock reverts to pre-deal standalone value (pre-announcement price ~$25-28 range based on 27% surge), implying ~30%+ downside from current price
Subscription revenue growth at mid-single digits and ROIC < WACC suggests the moat is not yet generating excess returns at scale—could indicate commodity pricing pressure or high cost of platform operation

Bruce Greenwald — 🟡 watch · 58/100 · medium confidence

LiveRamp is a genuine operating business with an earnings history long enough to apply EPV analysis. The core value question is whether EPV exceeds reproduction value (franchise) or merely matches it (commodity). Current data suggests a modest but real moat, a price already at or below EPV on conservative normalization, but the acquisition at $38.50 effectively caps the near-term return. EPV CALCULATION: Normalized operating income for FY2026 is reported at $83.5M (10.3% GAAP operating margin). This year appears to be an inflection year — prior three years showed negative or near-zero net income, so I must be cautious about using a single-year peak margin. I'll take a blended view: FY2023 operating margins were thin/negative; FY2024 was near breakeven; FY2025 (ended March 2026) shows $83.5M operating income on $813M revenue. The Q2 FY2026 call guided non-GAAP operating margin at 22%, implying non-GAAP OpInc of ~$178-182M but GAAP operating margin of only 10-11%. The delta is substantial stock-based compensation (historically elevated, though now -23% YoY per the transcript). I normalize by starting with GAAP operating income of ~$83.5M, but note this may still embed non-recurring items and migration costs. Adding back maintenance capex (capex is only $1.4M vs $148M FCF — suggesting almost all capex is maintenance for this asset-light model), distributable earnings approximate $83.5M * (1 - 0.21 tax rate) ≈ $66M after-tax, then capitalize at WACC of 10.1% = EPV of ~$650M at the operating level. Adding net cash of ~$141M (cash $396M minus long-term debt $255M), equity EPV ≈ $795M, or ~$13/share — well below current price of $37.70. However, this single-year normalization is punishingly conservative given the company only recently became profitable. If I use FCF of $149M as a better proxy for distributable earnings (the FCF margin is 18.3%, more reflective of the near-zero capex model), then EPV = $149M / 10.1% + $141M net cash = $1,617M equity value, or ~$27/share. Even on an FCF basis, the $37.70 current price exceeds this EPV by ~40%, meaning buyers are paying for growth. ASSET REPRODUCTION VALUE: LiveRamp is primarily an intangible-asset business. Tangible assets: $1.27B total assets minus goodwill/intangibles (not broken out precisely from filings excerpt) — likely $300-400M tangible. The real reproduction value lies in rebuilding the data network (20,000+ data attributes, identity graph spanning hundreds of millions of consumers), the customer relationships (132 million-dollar-plus accounts, 102% NRR), regulatory/privacy compliance infrastructure, and the established marketplace ecosystem. I estimate reproduction cost at $1.5-2.5B, which at $2.29B market cap means the market is paying roughly reproduction value — consistent with a modest but real moat, not a deep franchise. MOAT ASSESSMENT: There are genuine barriers: (1) Customer captivity via switching costs — data connectivity infrastructure is deeply embedded in customers' marketing stacks; migrations are costly and disruptive; (2) Network effects in the data marketplace — more data partners make the platform more valuable; (3) Some scale economies in identity resolution. However, barriers are not impregnable: AWS, Google, and The Trade Desk all have competing data infrastructure plays; clean room technology is proliferating; and ROIC of 5.4% is barely above a reasonable cost of capital, suggesting competition has already eroded returns significantly. EPV modestly exceeds tangible asset value but does not dramatically exceed full reproduction value — consistent with a weak-to-moderate moat, not a deep franchise. MARGIN OF SAFETY: At $37.70 (essentially the $38.50 deal price minus arb spread), the stock offers NO margin of safety on EPV — the market price is at or above even an optimistic EPV (~$27-35/share depending on normalization). The DCF provided ($49.52 intrinsic value) relies on 10.9% FCF growth sustained for 5 years with 73% of value in terminal value — exactly the kind of growth-dependent, terminal-value-heavy analysis I distrust. The acquisition price itself ($38.50) may represent fair value for Publicis as a strategic buyer with synergies, but for a standalone EPV investor, there is no margin of safety. The deal arb spread ($0.80 or ~2%) is the only near-term return available, with regulatory/termination risk as the downside.

Key points

FCF-based EPV of ~$27/share vs. current price $37.70 — paying ~40% premium to no-growth value, implying market is pricing in growth that may or may not be moat-protected
Moat is real but moderate: customer captivity (switching costs in data infrastructure) and marketplace network effects present, but ROIC of only 5.4% signals competition has eroded returns close to cost of capital
Acquisition by Publicis at $38.50/share effectively converts this to a ~2% arb trade; standalone fundamental debate is now moot in the near term
Revenue CAGR of 10.9% and FCF margin of 18.3% are solid for a data infrastructure business but not exceptional; the company only recently achieved consistent profitability (4 years of losses FY2021-2024)
Asset-light model (capex only $1.4M) means FCF ≈ free distributable earnings — favorable for EPV analysis; balance sheet is clean with net cash of ~$141M
Non-GAAP vs GAAP operating income divergence is large (~$178M vs $83M), driven primarily by SBC — important to not capitalize non-GAAP figures without adjustment

Red flags

Price at $37.70 offers zero margin of safety on conservative EPV; no-growth value is well below current price — buyers are paying entirely for growth
ROIC of 5.4% barely exceeds WACC of 10.1% — suggesting limited ability to generate value above cost of capital; moat may be narrower than management narrative implies
73% of DCF value sits in terminal value — precisely the long-dated, speculative component I treat as unreliable; acquisition price may be strategically motivated rather than fundamental-value-driven
Earnings history is volatile and only recently positive — normalization is genuinely difficult; FY2021-2024 aggregate net income was deeply negative, making any single-year EPV estimate uncertain
Heavy SBC ($94M+ differential between GAAP and non-GAAP operating income) represents real economic dilution that must be factored into distributable earnings — managements 22% non-GAAP margin flatters true owner earnings
Deal overhang means any standalone value creation thesis is suspended pending regulatory approval; termination risk (~$32M fee, business disruption) is a real downside

Terry Smith (Fundsmith) — 🟡 watch · 58/100 · medium confidence

LiveRamp presents a genuinely interesting quality profile but falls short of Fundsmith's highest bar on several key dimensions. On the positive side: the business is asset-light (capex of $1.4M on $813M revenue is trivially small), FCF of $149M converts at 18.3% FCF margin versus net income of $146M, suggesting excellent cash conversion with minimal accrual distortion. Operating margin of 10.3% GAAP (22%+ non-GAAP) is respectable for a software/data infrastructure business, and the company carries a clean balance sheet — net cash position with $396M cash versus $255M long-term debt. However, ROCE of 5.4% (ROIC per fundamentals) is well below Fundsmith's typical 20%+ threshold, and the historical earnings trajectory (losses in FY21, FY22, near-breakeven FY24) suggests the business only recently crossed into genuine profitability — this is not the multi-decade quality compounder Smith favours. The subscription revenue model (102% net retention, ARR inflecting) has recurring characteristics Smith rewards, but 7% ARR growth and mid-single-digit subscription revenue growth are modest for what should be a sticky platform. Most critically, the investment thesis is now moot in the near term: RAMP is under a $38.50/share Publicis acquisition offer. The stock at $37.70 represents a pure merger arbitrage situation (~$0.80 spread), not a long-term quality holding opportunity. Even setting aside the acquisition, the DCF intrinsic value of $49.52 implies 31% upside on a standalone basis — attractive — but RAMP's five-year profit history is too inconsistent and ROCE too low to meet Fundsmith's quality screen with confidence. The platform moat in data connectivity and clean rooms is real (network effects, switching costs), but monetisation has been lumpy. I assign a watch rather than a pass because the underlying business quality is improving but unproven across a full cycle, the ROIC is sub-standard for this school, and the current price is effectively capped by deal mechanics at $38.50.

Key points

Near-perfect cash conversion: FCF $149M vs net income $146M — no accrual distortion, highly asset-light with capex of only $1.4M on $813M revenue
Clean balance sheet — net cash of ~$141M; debt-to-equity 0.26x; no leverage risk flagged
Recurring subscription revenue with 102% net retention sits within Fundsmith's preferred revenue quality band
Operating margin now at record GAAP high (~10%); non-GAAP 22%+ with Rule of 40 target by FY28 shows credible margin expansion path
Data connectivity/clean room platform has genuine network effects and switching costs — the moat architecture Smith favours
DCF base case of $49.52 implies 31% standalone upside, suggesting a fair price for a decent (if not outstanding) business

Red flags

ROIC of 5.4% is far below Fundsmith's 20%+ threshold — the single most important disqualifier for this school
Consistent profitability only from FY25; prior years (FY21–FY24) showed net losses or near-zero earnings — insufficient multi-year quality track record
Acquisition by Publicis at $38.50 converts RAMP from a quality compounding investment into a merger arbitrage — not a Fundsmith situation
Revenue growth of ~9% and ARR growth of 7% are modest; compounding inside the company at high incremental returns requires higher growth rates to justify quality premium
Platform migration overhead dragged gross margin 3 points YoY — execution risk on cost structure; 73% terminal gross margin assumption needs proof
Historical pattern of running at losses raises questions about whether the moat is truly pricing-power-driven or scale-dependent; not a proven 'essential consumable' repeat-purchase franchise

Michael Mauboussin — 🟡 watch · 58/100 · medium confidence

LiveRamp presents a genuinely interesting competitive-advantage profile that is partially obscured by the pending Publicis acquisition at $38.50/share. From a Mauboussin expectations-investing lens, the stock at $37.70 is essentially a merger arb trade with a 2.1% spread to the deal price — the market-embedded expectations are almost entirely about deal closure, not standalone operating performance. I'll assess both the franchise quality (what Publicis is paying for) and the expectations embedded pre-deal, since the moat analysis remains relevant regardless of the M&A outcome.

ROIC vs. WACC: ROIC is reported at 5.42% against a WACC of ~10.1%. This is a meaningfully negative spread — capital is being deployed at roughly half the cost. ROE of 15.2% looks better but is partly a reflection of the equity base structure, not operational efficiency. The spread is thin and arguably negative in economic-profit terms. This is a critical red flag: the company has not demonstrably earned above its cost of capital on an ROIC basis. The 10.3% operating margin and 18.3% FCF margin are encouraging signs that the model is maturing, but ROIC below WACC means value destruction at the margin until the spread reverses. Historical net income was negative in FY21, FY22, FY24 — only recently (FY25) did the company post meaningful GAAP profitability. The trajectory is improving but the starting point is weak.

Moat Assessment: LiveRamp's competitive position rests on three partially overlapping mechanisms: (1) Network effects — the data collaboration platform becomes more valuable as more data providers and data buyers connect through it; the clean room ecosystem and the breadth of integrations (Netflix, Albertsons, Target Roundel, Uber, PayPal) create genuine indirect network effects as more participants make the matching layer more precise and monetizable. This is real and strengthening. (2) Switching costs — enterprise customers building identity resolution workflows, clean room deployments, and data marketplace integrations around LiveRamp's infrastructure face high switching costs: procedural (rebuilding integrations), relational (counterparty relationships), and financial (renegotiation). Subscription NRR of 102% and 132 million-dollar-plus customers at a new high support this. (3) Intangibles — the RampID identity graph and data connectivity infrastructure represent years of proprietary matching infrastructure. As third-party cookies deprecate and AI models require high-quality first/second-party signals, this asset appreciates. Overall moat rating: Narrow-to-Wide, trajectory Strengthening — but the mechanism is still being demonstrated in the financials rather than fully reflected in sustained high ROIC.

Expectations Embedded in the Pre-Deal Price: At ~$30/share pre-deal (late 2025 levels), the DCF with 10.9% FCF growth and 10.1% WACC produces an intrinsic value of $49.52 — suggesting the standalone story was underpriced. The deal at $38.50 represents roughly a 23% discount to DCF base case intrinsic value ($49.52) and is below even the bear scenario ($40.64). Publicis is acquiring a data collaboration moat at a price that implies modest, not heroic, growth expectations — which is actually consistent with what Mauboussin would call 'expectations too low' on the standalone basis. The deal price embeds essentially zero credit for the usage-based pricing model upside, AI monetization, or Rule of 40 trajectory. From an expectations-investing perspective, Publicis appears to be getting a bargain; existing shareholders are receiving fair-but-not-generous value.

Distribution of Outcomes (Current State): Given the announced deal at $38.50/share with stock at $37.70, the distribution is now binary: (A) deal closes — ~80% probability given routine regulatory profile of a French ad-holding company acquiring a US data-tech platform — yielding ~$38.50 or ~2.1% upside; (B) deal breaks — stock likely reverts to $28-32 range (pre-deal levels), representing 25-35% downside. Expected value: (0.80 × $38.50) + (0.20 × $30) = ~$36.80 — roughly in line with current price. This is a thin proposition. The fat tail risk is deal failure, and the upside from the base case is capped. The standalone bull case ($49-60) is now inaccessible without deal failure AND a re-rating, which is a complex, low-probability sequence.

Capital Allocation: Management has been disciplined — SBC down 23% YoY, buybacks actively executed ($80M YTD), balance sheet nearly debt-free ($396M cash). Offshoring OpEx improvements show cost discipline. No evidence of empire-building M&A. This is a positive signal on management process quality.

Key Uncertainty: ROIC below WACC is the central unresolved question. If the usage-based pricing model and AI positioning accelerate revenue growth AND margins expand toward Rule of 40 targets, ROIC could cross the cost of capital threshold meaningfully in FY27-28. But this is a forward expectation, not a demonstrated track record. The base rate for mid-size SaaS platforms achieving sustained ROIC above 10% from a below-WACC starting point is not high — mean reversion pressure is real.

Key points

ROIC at 5.42% is materially below WACC of ~10.1%, meaning economic profit is negative; the spread must widen before this becomes a true value-creating franchise
Moat mechanisms are real and partially defensible: indirect network effects (data collaboration ecosystem), high switching costs (enterprise workflow integration), and appreciating intangibles (RampID, clean rooms) as cookies deprecate — rated Narrow-to-Wide, trajectory Strengthening
Deal price of $38.50 appears below DCF intrinsic value of $49.52 (base case) — Publicis is acquiring the franchise at what looks like a discount; existing shareholders receive fair-but-not-generous value
Current stock at $37.70 vs $38.50 deal price creates a binary payoff: ~2% upside if closed, ~25-35% downside if deal breaks; expected value barely supports current price on a probability-weighted basis
Usage-based pricing model and AI monetization are real strategic options with positive early signals (overwhelmingly positive pilot feedback, 102% NRR) but are entirely absent from current guidance and therefore unpriced in the deal
Revenue CAGR of 10.9% and FCF margin of 18.3% show the model is maturing; operating leverage is real (non-GAAP op margin expanded 4 points YoY); trajectory toward Rule of 40 by FY28 is credible but not guaranteed

Red flags

ROIC (5.42%) well below WACC (10.11%) — the company is not yet demonstrably creating economic value; historical pattern of near-zero or negative net income (FY21-FY24) reinforces this concern
Binary deal-or-no-deal payoff structure means standalone franchise quality is temporarily inaccessible to new investors; the distribution of outcomes is asymmetrically skewed to the downside
Deal price ($38.50) represents a ~22% discount to DCF base intrinsic value ($49.52) — raises the question of whether the board adequately ran a competitive process; law firm fairness investigations are routine but not trivial
73.2% of DCF value is in the terminal value, making the intrinsic value estimate highly sensitive to terminal growth and WACC assumptions — a 50bps WACC increase or growth deceleration meaningfully reduces the base case
Platform migration overhead and dual-cloud costs have already dragged gross margin; if completion delays into FY27, margin expansion thesis stalls and the Rule of 40 target slips
AI monetization partnerships (Perplexity, Dappier) are early-stage and unquantified — management has cited no incremental revenue or customer examples of AI-driven upsells; risk of narrative-without-numbers

Chuck Akre — 🟡 watch · 55/100 · medium confidence

LiveRamp is a capital-light, recurring-revenue SaaS-adjacent data connectivity business with genuine switching costs and network effects — structurally interesting for the Akre framework. However, the three-legged stool test is incomplete: (1) The business has franchise qualities but ROIC is only 5.4%, well below Akre's ~20%+ threshold, and ROE of 15.2% is moderate; both reflect years of heavy investment and a history of near-zero or negative net income through FY2024. (2) Management has improved capital discipline — SBC down 23% YoY, offshoring driving margin expansion, buybacks active — but the company only turned consistently profitable in FY2025, so the track record of high-return reinvestment is short and unproven. (3) The reinvestment runway in AI-driven commerce media and CTV is real, but the usage-based pricing pilot is unproven at scale and AI monetization is speculative. Critically, the entire investment thesis is now moot for a long-term compounder: Publicis announced acquisition at $38.50/share, and the stock trades at $37.70 — a pure merger arbitrage spread. The business cannot be 'owned for years' as Akre requires; it is being acquired. The DCF intrinsic value of ~$49.52/share is above deal price, suggesting the deal arguably undervalues the business on a standalone basis, but that upside is not available to shareholders. For a new buyer today, this is a ~$0.80 arb spread on a deal pending regulatory and shareholder approval, not a compounding opportunity. Pre-deal fundamentals were improving but not yet at Akre-quality levels of sustained high-ROIC compounding.

Key points

Capital-light model: capex only $1.4M vs. $149M FCF; FCF margin of 18.3% is strong and improving
Revenue CAGR of ~10.9% over 3 years; ARR inflection with 7% YoY growth and record million-dollar-plus customer count (132)
FY2025 marks first clean year of consistent profitability; net income $146M vs. near-zero or negative in prior years
Franchise characteristics present: network effects in data collaboration, switching costs via clean room integrations, first-party data moat as cookies fade
DCF intrinsic value ~$49.52 suggests business was modestly undervalued on standalone basis before deal announcement
Buybacks active ($80M YTD, $177M authorization remaining) and SBC declining — improving capital allocation signals
Usage-based pricing pilot and AI partnerships represent real but unquantified reinvestment opportunities
Balance sheet strong: $396M cash, low leverage (D/E 0.26), current ratio 2.7x

Red flags

ROIC of only 5.4% is far below Akre's ~20%+ quality threshold; ROE of 15.2% is acceptable but not exceptional, and both metrics have short positive track records
Acquisition by Publicis at $38.50/share eliminates the compounding thesis entirely — this is now a merger arbitrage, not a long-term compounder
Deal price of $38.50 is below DCF intrinsic value (~$49.52), meaning shareholders may be selling at a discount to standalone value
Regulatory and shareholder approval risk: 10-K explicitly cites deal termination fees (~$32M), litigation risk, and business disruption as material risks
Platform migration has compressed gross margins (delayed optimization); management admitted it is 'taking longer than expected'
Years of negative or near-zero net income (FY2021–FY2024) means the compounding track record is only one year old — insufficient for Akre-style conviction
AI monetization entirely unquantified; partnerships with Perplexity/Dappier are early-stage with no revenue attribution
SaaS-style subscription growth only mid-single digits (+5–6% YoY); not the explosive reinvestment economics Akre prizes

Joel Greenblatt — 🟡 watch · 55/100 · medium confidence

LiveRamp is a profitable, operating business with measurable EBIT and invested capital — Greenblatt criteria apply. However, the Magic Formula analysis reveals a mixed picture: the earnings yield is decent but not exceptional, and ROIC on tangible capital is understated by accounting but structurally limited by the asset-light but intangible-heavy nature of the business. The dominant near-term reality is that this is now a merger arbitrage situation — Publicis acquiring RAMP at $38.50/share vs. current price of $37.70 — which is a Greenblatt-style special situation, but with very limited upside (~2% spread) and modest regulatory/completion risk rather than a deep-value catalyst. On standalone fundamentals: EBIT of ~$83M on an EV of roughly $2.15B (market cap ~$2.29B + LTD ~$255M - cash ~$396M = ~$2.15B) yields an EBIT/EV earnings yield of about 3.9% — below the 6-8%+ threshold Greenblatt typically requires for a 'cheap' ranking. ROIC on tangible capital is harder to pin down: net working capital is approximately $429M (current assets $679M - current liabilities $250M), and net fixed assets are minimal given the software/data business model, so tangible invested capital is dominated by working capital (~$430M). EBIT/tangible capital = $83M/$430M ≈ 19% — that's a respectable return on tangible capital, signaling a good business quality. But the earnings yield is weak at ~3.9%, meaning the stock is not cheap on an enterprise basis even before the acquisition premium. The FCF yield is better ($149M FCF vs. $2.15B EV = ~6.9%), but GAAP EBIT is the Greenblatt numerator, and at $83M it reflects real operating leverage still building. The $146M net income includes significant non-operating items that inflate reported earnings beyond EBIT. As a special situation: the $38.50 deal creates a hard-catalyst path to value realization, but with only ~2% spread remaining and deal risk (regulatory approval, termination risk per 10-K filings noting ~$32M termination fee), this is not the kind of mispriced special situation Greenblatt describes — forced selling and institutional neglect created the opportunity pre-announcement, not post. The window for the Greenblatt-style entry has largely closed. Revenue growing at ~11% CAGR with improving margins and strong FCF conversion ($149M FCF, 18.3% margin) demonstrates the business quality axis, but the pricing axis is now constrained by the deal price ceiling. Net-net: good business quality (high ROIC on tangible assets, strong FCF) but poor earnings yield at current EV; special situation upside is ~2% to deal close, not the asymmetric return Greenblatt seeks.

Key points

EBIT/EV earnings yield ~3.9% ($83M EBIT / ~$2.15B EV) — below Greenblatt's 'cheap' threshold of ~6-8%+
ROIC on tangible capital ~19% ($83M / ~$430M net working capital + minimal fixed assets) — scores well on quality axis
Magic Formula verdict: good business (high ROIC) but not cheap (low earnings yield) — fails the combined ranking
Special situation: Publicis acquisition at $38.50/share announced May 2026; only ~2% spread at $37.70 current price — limited asymmetric upside remaining
FCF of $149M (18.3% margin) confirms real cash-generative economics; $83M GAAP EBIT understates true earning power vs. $146M net income which includes non-operating items
Balance sheet strong: $396M cash, minimal tangible debt, current ratio 2.7x — no survival risk, but excess cash is already in EV calc
Revenue CAGR 10.9% over 3 years with improving operating margins (10.3% GAAP, 22%+ non-GAAP) — business quality improving
Pre-announcement entry (below $30) would have scored 70+ on Greenblatt criteria; post-announcement the opportunity has largely closed

Red flags

Low earnings yield on EV basis (~3.9%) fails the 'cheap price' axis of the Magic Formula — stock is not a bargain at current EV
Acquisition deal ceiling at $38.50 removes meaningful upside; only ~2% spread makes this a low-return special situation post-announcement
$146M net income significantly exceeds $83M GAAP EBIT — non-operating items inflate reported earnings; normalized EBIT is the true Greenblatt numerator and it's modest
Termination risk per 10-K: regulatory/shareholder approval pending, $32M termination fee, business disruption risk if deal fails — deal failure would likely reprice stock well below current levels
ROIC calculation complicated by intangible-heavy balance sheet (technology/data platform); tangible capital base may overstate or understate true economic capital employed
No insider alignment catalyst in the classic spinoff/restructuring sense — this is a straightforward cash acquisition with limited Greenblatt-style special situation complexity
Post-deal, this is pure arbitrage with 2% max gain vs. deal-break downside of potentially 15-25% — poor risk/reward for a value investor

Warren Buffett — 🟡 watch · 52/100 · medium confidence

LiveRamp operates in the data connectivity and identity resolution space — a technology business I can partially understand at a high level. The company acts as a trusted intermediary enabling advertisers and data owners to connect first-party data without exposing raw PII, which gives it a plausible network-effect moat as more participants join the ecosystem. However, several Buffett criteria are problematic. First and foremost, the investment thesis is now fundamentally an M&A arbitrage play: Publicis announced a $38.50/share acquisition in May 2026, and the stock trades at $37.70 — a mere $0.80 spread. There is no margin of safety for a long-term equity holder; this is a deal arbitrage, not a quality business purchase at a fair price. Setting aside the deal overlay, the standalone business has meaningful quality markers: revenue CAGR of ~11% over 3 years, FCF of $149M (18.3% FCF margin), P/E of 15.7x, price-to-FCF of 15.4x, very low leverage (debt-to-equity 0.26), and a clean balance sheet with $396M cash. The DCF intrinsic value of $49.52/share would imply a 31% upside on a standalone basis, which is modestly attractive if the deal were not in place. But the earnings history is problematic from a Buffett lens: net income was deeply negative in FY2022 (-$119M), near zero in FY2023 and FY2024, and only turned sharply positive in FY2025 ($146M). This erratic earnings trajectory does not resemble the consistent, predictable earnings stream I require. ROIC at 5.4% is well below my 15%+ threshold. Stock-based compensation has historically been substantial (though declining -23% YoY), diluting owner earnings. The business model — selling data collaboration tools in an industry rapidly being reshaped by AI, privacy regulation, and cookie deprecation — is also at the outer edge of my circle of competence for forecasting a decade out. Management appears capable (Rule of 40 roadmap, disciplined buybacks, offshore cost savings), and the data moat is real but not yet proven to be durable against large platform incumbents (Google, Meta, Amazon). The acquisition by Publicis at $38.50 essentially caps the upside and confirms that the strategic value is real — but it also means I'm buying into deal risk, not business ownership.

Key points

Acquisition announced at $38.50/share by Publicis; stock at $37.70 means this is an M&A arbitrage with ~$0.80 spread, not a standalone quality investment opportunity
Standalone DCF intrinsic value estimated at $49.52/share (31% upside) suggests business was reasonably priced before deal, but deal now caps the upside
FCF of $149M at 18.3% margin and price-to-FCF of 15.4x are attractive quality metrics for the standalone business
Balance sheet is conservative: debt-to-equity 0.26, $396M cash, long-term debt appears modest relative to equity
Revenue CAGR of 10.9% over 3 years and improving operating margins (10.3% GAAP operating margin, record for company) show genuine business improvement
Network-effect moat plausible: data collaboration platform benefits from more participants, and switching costs are real once first-party data infrastructure is integrated

Red flags

Erratic earnings history disqualifies the business from Buffett's consistency standard: net losses in FY2022 (-$119M), FY2024 (-$1M), only profitable in FY2023 ($12M) and FY2025 ($146M) — not a decade of predictable earnings
ROIC of only 5.4% is well below the 15%+ threshold I require; ROE of 15.2% is borderline and only just achieved
Business model at outer edge of circle of competence: data identity resolution in rapidly shifting AI/privacy/cookie-deprecation landscape is difficult to forecast 10 years out
M&A deal overlay eliminates margin of safety for new investors: buying at $37.70 with deal price at $38.50 means you are taking regulatory/execution risk for $0.80 of upside
SBC has been historically high (improving but still material); owner earnings meaningfully below reported GAAP earnings
No identifiable pricing power evidence comparable to Buffett standards: revenue growth is solid but subscription growth is only mid-single digits and ARR growth 7% YoY — not a pricing-power compounder

Ray Dalio — 🟡 watch · 52/100 · medium confidence

LiveRamp is a data connectivity/SaaS business that is balance-sheet light and operationally self-funding — characteristics I generally reward. However, the investment case is now dominated by a pending acquisition (Publicis at $38.50/share), meaning this is effectively a merger arbitrage instrument trading at $37.70. The pure macro/regime stress-test is secondary to deal execution risk, which introduces a binary outcome: deal closes near $38.50 (minimal upside from here), or deal breaks and stock reverts toward pre-announcement levels (likely $25-30 range). From a Dalio-framework lens, RAMP has genuine strengths: net-cash balance sheet (~$396M cash vs. modest $254M long-term debt, net debt negative at -$141M), strong FCF generation ($149M), minimal capex ($1.4M), and a subscription-heavy revenue model that is not directly tied to credit cycles or consumer financing. Operating margin is positive (10.3% GAAP, ~22% non-GAAP) and improving. These are hallmarks of a business that can survive a regime shift without balance sheet distress. However, RAMP fails my regime-robustness test on several dimensions: (1) Ad-tech revenue is acutely cyclical — advertising budgets are among the first items cut in a deflationary bust or stagflation scenario, making RAMP's cash flows highly regime-dependent on the 'rising growth + low inflation' box; (2) The business has meaningful single-regime dependence — it thrives when brand advertising budgets grow, when digital transformation investment is robust, and when enterprise tech spending is healthy, all conditions that deteriorate sharply in a credit contraction or stagflationary environment; (3) Subscription net retention of 102% and mid-single-digit ARR growth of 7% YoY suggest the business is not generating true pricing power sufficient to offset inflation-driven cost pressures; gross margin compressed 3 points due to platform migration and cloud costs, indicating weak inflation pass-through at the cost level. The balance sheet is clean — current ratio 2.72, D/E 0.26, and the long-term debt of $254M appears modest — but I note the filing periods are inconsistent (liabilities dated 2019, LT debt dated 2015), which creates data quality uncertainty. The company is US-centric with limited geographic diversification of cash flows, adding concentration risk relative to a globally balanced portfolio. From a portfolio-construction standpoint, RAMP's beta of 1.28 and its correlation to broad tech/ad-spend cycles means it adds to, rather than diversifies, a typical equity book. As an M&A arbitrage at current prices, the risk/reward is asymmetric to the downside: $0.80 of upside to deal close vs. potentially $10+ of downside if the deal breaks and the stock re-rates to pre-announcement fundamental value. Regulatory and shareholder approval risks are real. The law firm investigation, while routine, reflects procedural friction. The DCF suggests intrinsic value of ~$49.52/share (31% upside to current price), which would be realized only if the deal breaks AND the standalone story re-accelerates — a scenario requiring both a negative and a positive catalyst simultaneously. The valuation is not egregious on a standalone basis (P/E 15.7x, price-to-FCF 15.4x, P/S 2.82x), suggesting the business is not priced for permanent low-rate perfection, which is a mild positive from a regime-shift cushion perspective.

Key points

Net-cash balance sheet (-$141M net debt) with $396M cash and minimal capex ($1.4M) — self-funding through any reasonable downturn without capital markets access
FCF of $149M (18.3% margin) demonstrates genuine cash generation capacity across cycles, though FCF history data is incomplete in the fact base
Current ratio of 2.72 and D/E of 0.26 indicate no near-term balance sheet distress or maturity wall concerns
Subscription revenue model (~75% of mix) provides more stability than purely transactional ad-tech peers, reducing peak-to-trough earnings volatility
No floating-rate debt concern given net-cash position; rate sensitivity is more indirect (via customer ad-spend budgets) than direct
DCF intrinsic value of $49.52/share implies meaningful standalone upside IF deal breaks, providing a partial floor on valuation

Red flags

Single-regime dependence: ad-tech and enterprise data spending is acutely pro-cyclical, collapsing in stagflation or deflationary bust scenarios — RAMP does not hold up across all four macro boxes
M&A arbitrage dynamic creates binary risk: only $0.80 upside to deal close at $37.70 vs. $38.50 deal price, but $8-12+ downside if regulatory or shareholder approval fails
Weak inflation pass-through: gross margins compressed 3 points YoY due to cloud and platform costs; subscription pricing (NRR 102%) barely keeps pace with inflation — real revenue durability is questionable
US-centric revenue concentration with limited geographic diversification, adding exposure to dollar-cycle and US-specific credit contraction risk
Beta of 1.28 means RAMP amplifies broad equity market drawdowns — adds correlation, not diversification, to a typical portfolio; fails Dalio's Holy Grail test
Inconsistent filing period dates in fundamentals data (liabilities dated 2019, LT debt dated 2015) create uncertainty about true balance sheet composition — fact base has data quality issues
Platform migration overhead and dual-cloud costs are ongoing, creating execution risk on margin expansion that management promised for Q4 FY26 — if delayed, FY27 profitability guidance could slip

Philip Fisher — 🟡 watch · 52/100 · medium confidence

LiveRamp presents a mixed Fisher-lens picture that has been fundamentally complicated by the announced Publicis acquisition at $38.50/share. As a standalone growth story, RAMP has genuine positive attributes — a data connectivity platform with defensible network effects, improving ARR trajectory, and meaningful positioning in commerce media and AI-driven advertising — but several Fisher criteria fall short or are now rendered moot by the M&A event. Revenue CAGR of ~10.9% over 3 years is above-average but not spectacular for a technology platform. Subscription growth at mid-single digits (5-7% YoY) is below what Fisher would demand for a high-conviction long-term hold. The usage-based pricing pilot is genuinely interesting as a land-and-expand mechanism, but management explicitly stated no FY26 upside is baked in, and benefits accrue 'over several quarters' in FY27 — this is future optionality, not current execution. On the positive side: FCF margins of 18.3%, operating margin expansion to 10.3% GAAP (record quarterly highs per management), disciplined SBC reduction of 23% YoY, and offshoring-driven cost leverage all signal a maturing, well-run organization. Management's candor on the pricing pilot limitations, macro conservatism in guidance, and gross margin compression from platform migration is commendable — this is Fisher-style honest communication. The million-dollar-plus customer count reaching a record 132 with net retention at 102% shows the product is valued. However, Fisher's core test is whether this company has a multi-year organic growth runway that justifies a buy-and-hold indefinitely posture. With the acquisition announced, that question is moot for the stock as a standalone compounder. The stock trades at $37.70 versus the $38.50 deal price — essentially a closed-end arbitrage. Fisher would not hold a company into an acquisition; he seeks compounders that self-perpetuate value creation over decades. The acquisition terminates that runway. Additionally, the historical earnings volatility (losses in FY21, FY22, FY24; large profit in FY25 of $146M after -$1M in FY24) raises questions about earnings quality and sustainability that the Fisher lens takes seriously.

Key points

Revenue CAGR of ~10.9% over 3 years is above-average but modest for a Fisher-grade growth candidate; subscription growth at 5-7% is below his threshold for outstanding organic growth
Usage-based pricing pilot represents genuine Fisher-style product innovation and TAM expansion — land-and-expand with lower entry point is structurally sound if it scales
FCF margin of 18.3% and record GAAP operating margin with disciplined SBC reduction (-23% YoY) reflect cost discipline Fisher would approve
Management candor on gross margin compression, pricing pilot limitations, and macro conservatism signals honest stewardship — a key Fisher criterion
Commerce media and CTV expansion (Netflix, Uber, PayPal, United Airlines partnerships) show product pipeline converting into new markets — Fisher Point 3 strength
Rule of 40 target by FY28 (10%+ growth + 30% margin) is credible but not yet proven; FY26 sits at Rule of 31
Publicis acquisition at $38.50/share fundamentally ends the standalone compounder thesis Fisher requires for a long-term hold

Red flags

Subscription revenue growth of 5-7% YoY is far below what Fisher demands for high-conviction long-term organic growth leadership
Earnings quality is erratic: FY21 -$34M, FY22 -$119M, FY23 +$12M, FY24 -$1M, FY25 +$146M — sustainable profitability only recently achieved, raising franchise durability questions
Platform migration taking 'longer than expected' per CFO — gross margin compressed 3 points YoY; execution risk on a core infrastructure promise is a Fisher red flag
AI monetization is entirely unquantified — partnerships with Perplexity, Dappier announced but no revenue attribution or customer examples of AI-driven upsells provided
Acquisition by Publicis terminates any multi-decade compounding thesis; stock is now a merger arbitrage at $37.70 vs $38.50 deal price, not a growth holding
R&D investment levels and competitive position versus clean room peers (Habu, InfoSum) not explicitly quantified in available filings — scuttlebutt on competitive moat is incomplete
Thin management depth disclosure in available fact base; no visibility on bench strength below CEO Scott Howe and CFO Lauren Dillard

Peter Lynch — 🟡 watch · 52/100 · medium confidence

LiveRamp is an understandable data connectivity and clean-room business — I can explain it in a sentence: it helps brands, publishers, and retailers link their first-party customer data safely to power targeted advertising without sharing raw data. That passes my 'invest in what you understand' test. But when I apply my actual criteria, the picture is mixed and now heavily complicated by the Publicis acquisition at $38.50/share.

CATEGORY: Stalwart trending toward fast grower. Revenue CAGR of ~10.9% over 3 years and operating margins now positive and expanding (~10% GAAP, ~22% non-GAAP) put it squarely in stalwart territory — not a 20-25% fast grower. Stalwarts I buy for 30-50% gains and move on; I don't hold forever.

PEG CHECK: The reported PEG is 1.44. That's above my 1.0 threshold and meaningfully above my 0.5 'excellent' bar. P/E of 15.7x on a business growing earnings at roughly 10-11% per year — that's a PEG that doesn't excite me. Not terrible, but not the bargain I want. If I use FCF yield (price-to-FCF of 15.4x) against ~11% FCF growth, same conclusion: PEG ~1.4. For a stalwart, I'd want to see P/E closer to the growth rate or below it.

EARNINGS GROWTH QUALITY: Net income swung wildly — losses in 2021-2022, near-breakeven in 2023-2024, then $146M in FY2025. The FY2025 profit jump looks large but may include one-time items; Yahoo Finance noted 'robust earnings are conservative,' suggesting some quality. ARR growing 7% YoY, subscription +5-6% — not explosive. Usage-based pricing pilot is promising but explicitly NOT in FY26 guidance. Management targets Rule of 40 by FY28 (growth + margin = 40) — that's a believable but not yet proven story.

BALANCE SHEET: Excellent. Net cash positive (~$396M cash vs ~$255M long-term debt = net cash ~$141M). Current ratio 2.7x. Debt-to-equity only 0.26x. This is exactly what I like — the company funds itself internally, no looming maturity risk.

THE ACQUISITION COMPLICATION: The $38.50/share Publicis deal announced May 18, 2026, fundamentally changes what this is. The stock at $37.70 is trading $0.80 below the deal price — pure merger arbitrage, not a growth investment. The upside to deal close is ~2%. The downside if the deal breaks is material (stock was ~$30 pre-announcement surge). This is no longer a Lynch growth story; it's a spread trade. I don't play M&A arbitrage — that's a different craft entirely. Law firm investigations (routine) and deal risk (regulatory approval pending) add uncertainty.

NEGLECT FACTOR: Gone. The acquisition announcement put RAMP in every headline. Retail piled in. Institutional interest is high. The neglected-stock edge that would make me excited is completely absent now.

AI POSITIONING: Interesting but speculative. Partnerships with Perplexity, Adobe, etc., and clean-room AI infrastructure are real strategic assets. But management has not quantified AI-driven revenue. This is a 'next chapter' story, not a proven roll-out formula yet.

BOTTOM LINE FOR MY LENS: Before the deal, RAMP at ~$30 with PEG ~1.1-1.2 and a nascent profitability inflection would have been a solid watch/mild buy as a stalwart with improving fundamentals. At $37.70 with a $38.50 deal pending, there's essentially no growth-investor upside — the stock is priced for deal closure, not for standalone earnings growth. I'd neither buy it as a growth story nor sell short the arb. It's a watch — I'd want to own it only if the deal breaks and the stock drops to where the standalone PEG becomes compelling again (sub-1.0).

Key points

Stalwart category: ~11% revenue CAGR, now profitable with 18% FCF margin — not a fast grower but a solidly improving business
PEG of 1.44 is above my 1.0 threshold; price-to-FCF of 15.4x on ~11% growth leaves no margin of safety for a Lynch buyer
Balance sheet is excellent: net cash ~$141M, D/E 0.26x, current ratio 2.7x — no balance sheet risk
ARR inflection (best net new ARR in 7 quarters) and usage-based pricing pilot are genuine growth catalysts for FY27+
Adobe partnership and CTV/commerce media expansion show a believable 'next leg' roll-out formula
Business is explainable in one sentence — passes my 'invest in what you understand' test

Red flags

Acquisition at $38.50/share makes this merger arb, not a growth investment — upside to deal close is only ~2%
Stock is no longer neglected; 27% surge on announcement, heavy news coverage, retail piling in — the easy money is gone
PEG 1.44 is above my buy threshold; I want PEG at or below 1.0 for a stalwart, ideally 0.5 for a fast grower
Subscription revenue growth only 5-6% YoY — below stalwart expectations; ARR inflection promising but not yet proven in revenue numbers
Usage-based pricing upside explicitly excluded from FY26 guidance — management itself is not confident enough to bake it in
AI monetization is unquantified — partnerships exist but no revenue attribution; risk of hype over substance
If deal breaks, stock likely drops 15-20% to pre-announcement levels, making current price a poor risk/reward for a standalone growth bet

Howard Marks — 🟡 watch · 52/100 · high confidence

RAMP is now effectively an M&A arbitrage situation, not a standalone fundamental investment. The $38.50/share all-cash Publicis deal announced May 18, 2026 dominates the investment thesis. At $37.70 current price, the spread is only $0.80 (2.1% gross, maybe 3-4% annualized depending on close timeline), offering minimal risk/return skew for a new entrant. The more interesting question is whether the standalone fundamentals would justify accumulation if the deal breaks—and here the picture is mixed but moderately constructive from a Marks-style risk perspective. On the positive side: the balance sheet is genuinely strong (no meaningful debt at the holding level, $396M cash, D/E 0.26, current ratio 2.7), FCF is real and growing ($149M, 18.3% FCF margin), and the business turned the corner from chronic losses to profitability only recently. The DCF suggests ~31% upside to $49.52 intrinsic value versus a $37.70 current price, and even the bear case ($40.64) is above current price—suggesting the standalone equity has a floor with material upside if growth re-accelerates. Revenue CAGR of 10.9% at a 2.82x price/sales and 15.4x price/FCF is not expensive for a recurring-revenue data infrastructure business. However, the risk framework reveals several concerns. First, the stock is no longer priced for pessimism—it surged 27% on the deal announcement and trades at essentially the deal price, meaning no fear or forced selling is present. The contrarian/fear-driven setup Marks rewards most is absent. Second, the arbitrage spread is razor-thin (2.1%) with real downside: if the deal breaks (regulatory rejection, material adverse change, or shareholder/legal challenge), the stock likely re-prices to pre-announcement levels around $29-30, representing ~20-22% downside from current levels. That is deeply asymmetric in the wrong direction for a new position. Third, sentiment has shifted from pessimism to deal celebration—retail chatter is deal-euphoric, law firm investigations filed within hours are routine, but the crowd is now 'long the deal' which is exactly the crowded consensus Marks penalizes. Fourth, while the business is improving, the growth rate (8-10% revenue, subscription stuck in mid-single digits) is modest; the bull case requires successful deployment of usage-based pricing (unproven at scale, no FY26 guidance credit), AI monetization (speculative), and platform migration completing on schedule (execution risk). The DCF terminal value comprises 73% of enterprise value—highly sensitive to terminal growth assumptions and WACC, and the 10.87% revenue CAGR used as FCF growth proxy may be generous given current subscription trajectory. From a cycle perspective, the deal was struck in a period of continued technology M&A activity and relatively accommodative conditions for large-cap acquirers; the deal price itself (~2.7x EV/Revenue, ~15x EV/FCF) is not a distressed-seller price but a fair-to-modest control premium. Bottom line: Marks would not initiate here because (a) upside is capped at ~2% if the deal closes, (b) downside is 20%+ if it breaks, (c) no margin of safety exists at deal price—you are betting on deal completion not buying value below intrinsic worth, and (d) sentiment is benign-to-positive, not panicked. If the deal were to break and the stock fell to $28-30, the standalone FCF yield (~5%), improving profitability, clean balance sheet, and 30%+ discount to DCF intrinsic value would create a genuinely interesting setup. Watch, not buy, unless price falls materially on deal disruption news.

Key points

Clean balance sheet with $396M cash, minimal real debt, 2.7x current ratio—financial structure can survive deal failure or macro stress without permanent impairment
FCF of $149M (18.3% margin) is real and growing; P/FCF of 15.4x is not expensive for recurring-revenue software if growth sustains
DCF intrinsic value of $49.52/share implies 31% upside to standalone fair value; even bear case ($40.64) exceeds current price—value floor exists below current deal price
Revenue turned profitable ($146M net income FY2025 vs. losses in 2021-2024); business model maturing with operating leverage emerging
M&A arbitrage spread of 2.1% ($37.70 vs. $38.50 deal price) is deeply unattractive risk/reward for new capital—upside capped, downside open
If deal breaks and stock reverts to pre-announcement ~$29-30, standalone value case becomes compelling at ~30-35% discount to DCF intrinsic value

Red flags

Asymmetric risk/reward is backwards: 2.1% gross upside if deal closes vs. ~20-22% downside if deal breaks—classic 'picking up pennies in front of a steamroller' for new entrants
Sentiment is deal-euphoric, not fearful—crowd is universally long the arbitrage; no contrarian element present; retail chatter celebrating gains, not capitulating
Terminal value represents 73% of DCF enterprise value—extremely sensitive to terminal growth/WACC assumptions; any growth disappointment or discount rate expansion collapses intrinsic value
Regulatory and shareholder approval risk is real: 10-K explicitly flags termination fees (~$32M), regulatory delays, talent/customer attrition as deal risks
Subscription revenue growth stuck in mid-single digits (5-6% YoY); usage-based pricing model upside explicitly excluded from all FY26 guidance—revenue re-acceleration unproven
Platform migration dragging gross margin; CFO acknowledged delays; if Q4 FY26 completion slips into FY27, margin expansion story pushed out and Rule-of-40 target becomes more speculative

Charlie Munger — 🟡 watch · 52/100 · medium confidence

LiveRamp is an understandable, asset-light data connectivity business operating in a definable space — helping brands and publishers activate first-party data for advertising. The moat concept is real: network effects from being embedded in data clean rooms, switching costs from deep customer integrations, and a data marketplace that benefits from multi-sided network dynamics. However, the assessment is fundamentally complicated by the announced Publicis acquisition at $38.50/share (May 2026), which transforms this from a standalone quality evaluation into an M&A arbitrage question. Setting that aside to evaluate business quality: RAMP has made genuine progress toward profitability (net income swung to $146M in FY2025 from losses in prior years), FCF of ~$149M at an 18.3% margin is respectable, and ROIC of 5.4% is below my 15%+ threshold for a great business. The ROIC shortfall is the central quality concern — a genuinely great business should earn well above its cost of capital on tangible equity, and RAMP is not there yet. Operating margin of ~10% is thin for a software-oriented platform. The subscription revenue growth stalling at mid-single digits, the platform migration drag on gross margins, and the pricing model still in pilot phase suggest the moat is real but not yet fully monetized into the financial returns I demand. Management commentary is candid and the balance sheet is clean ($396M cash, modest debt), but stock-based compensation historically has been dilutive and the path to Rule of 40 by FY28 requires execution on multiple simultaneous initiatives. The DCF at $49.52 intrinsic value suggests ~31% upside from $37.70, which is interesting but the 73% terminal value weighting means the DCF is mostly a bet on sustained compounding — which I cannot underwrite confidently given sub-threshold ROIC. With the acquisition at $38.50 essentially capping near-term upside and adding deal closure risk, this sits firmly in watch territory rather than a clear quality pass.

Key points

Real but imperfectly monetized moat: data clean room network effects and switching costs are genuine, but ROIC of only 5.4% is well below Munger's 15%+ quality threshold
Business has turned profitable with $146M net income and $149M FCF in FY2025 — a genuine inflection from years of losses, but durability of profitability unproven across cycles
Clean balance sheet: $396M cash, modest long-term debt, current ratio of 2.7 — survives a downturn without capital impairment risk
Subscription net retention of 102% and record million-dollar-plus customer count (132) show the platform is sticky, but 102% NRR is not exceptional for a high-quality SaaS moat
Acquisition at $38.50/share announced May 2026 means standalone quality thesis is now moot; stock at $37.70 is essentially an arbitrage on deal closure
DCF intrinsic value of $49.52 assumes sustained 10.9% FCF growth at 10.1% WACC — reasonable but dependent on margin expansion execution that remains unproven
Management appears candid (explicit guidance conservatism on pricing pilot, honest about gross margin drag) and capital allocation is rational (buybacks, zero dilution guidance)

Red flags

ROIC of 5.4% is far below the 15%+ threshold Munger requires for a 'great business' — the moat is not yet translating into exceptional returns on invested capital
Operating margin of only 10.3% for a software/data platform suggests pricing power is constrained or cost structure is heavier than a dominant franchise should carry
Subscription revenue growth stalled at mid-single digits — a platform with genuine network effects should compound faster; this signals competitive pressure or TAM limitations
73% of DCF value resides in terminal value, making the intrinsic value estimate highly sensitive to long-run assumptions that cannot be reliably forecast
Acquisition overhang: deal introduces regulatory risk, termination fees, talent/customer disruption — and if deal fails, stock could revert to pre-announcement levels (~$29-30)
Stock-based compensation historically dilutive; while improving (-23% YoY in Q2), total shares outstanding and equity dilution history require scrutiny
Platform migration delays have compressed gross margins and extended timeline to margin targets — execution risk on a multi-year modernization is a real concern

Benjamin Graham — 🟡 watch · 48/100 · medium confidence

LiveRamp presents a mixed picture through a strict Graham lens. The company has achieved genuine profitability and reasonable balance-sheet quality, but several Graham criteria are not met — most importantly, the earnings record is erratic (losses in 2021, 2022, 2024; profit only recently stabilized), no dividend is paid, and the P/E and P/B multiples, while not outrageous, exceed Graham's conservative thresholds. The acquisition announcement at $38.50/share further complicates matters: the stock at $37.70 represents a classic arbitrage situation, not a value purchase, and the intrinsic value question is now moot for standalone analysis. The DCF intrinsic value of ~$49.52 suggests modest margin of safety on a standalone basis (~31% upside), but this is below Graham's preferred one-third discount threshold and the DCF relies on continued ~10.9% FCF growth — a forecast-dependent assumption Graham would distrust. The balance sheet is genuinely sound: current ratio of 2.72, cash of $396M, and modest long-term debt relative to equity. However, the P/E of 15.7x sits right at Graham's defensive ceiling of 15x and P/B of 2.38x yields a P/E × P/B product of ~37.4, well above the 22.5 threshold. Net current asset value (NCAV = current assets $679M minus total liabilities; but total liabilities figure in the fact base appears to reference a 2019 period — data quality issue flagged) cannot be cleanly computed from available data. The operating cash flow period listed as 2013-03-31 is clearly a data artifact and should be disregarded. The net income swings — from -$119M (2022) to +$146M (2025) — violate Graham's requirement for positive earnings every year over the look-back period. The acquisition context converts this into an M&A arbitrage with an ~$0.80 spread ($38.50 deal price minus $37.70 market price), which is not a Graham value investment. On pure standalone fundamentals, this is a borderline watch — cheap enough to be interesting but not cheap enough to clear Graham's hurdles definitively.

Key points

Current ratio of 2.72 meets Graham's minimum of 2.0; cash of $396M with relatively modest liabilities is positive
P/E of 15.7x sits at Graham's defensive ceiling of 15x; P/E × P/B = 37.4, well above the 22.5 threshold — no deep value here
DCF intrinsic value of $49.52 implies ~31% upside from $37.70, just below Graham's preferred one-third margin of safety
Revenue has grown consistently from $529M (2021) to $813M (2025), a ~54% increase over five years — adequate size and growth, but modest
FCF of $149M and FCF margin of 18.3% demonstrate real cash generation; price-to-FCF of 15.4x is reasonable but not cheap
Debt-to-equity of 0.26 and long-term debt of ~$255M (noting data period inconsistency) appear manageable relative to equity of $962M
Acquisition at $38.50/share turns this into a merger arbitrage with an ~$0.80 spread — a different risk/return calculus than value investing

Red flags

Earnings instability: net losses in 2021 (-$34M), 2022 (-$119M), and 2024 (-$1M) violate Graham's requirement for consistent positive earnings over the look-back period
No dividend history — Graham's defensive investor requires uninterrupted dividends over a long record; LiveRamp pays none
P/E × P/B product of ~37.4 significantly exceeds Graham's 22.5 composite threshold, indicating the stock is not cheap on both metrics simultaneously
Data quality issues in fact base: operating cash flow period listed as 2013 (clearly erroneous), total liabilities period listed as 2019 — NCAV cannot be cleanly computed
Acquisition overhang: stock is now trading as M&A arbitrage near deal price; standalone value analysis is subordinated to deal risk (regulatory, shareholder approval, termination)
No net-net condition: current assets of $679M minus even partial liabilities far exceeds market cap of ~$2.3B — deeply negative net-net margin
SBC had been elevated historically; while -23% YoY in Q2, cumulative dilution is a concern Graham would note in assessing per-share earnings quality

Stanley Druckenmiller — 🔴 avoid · 28/100 · high confidence

RAMP is now a pure merger arbitrage situation, not a directional macro/earnings play. Publicis announced acquisition at $38.50/share; the stock trades at $37.70 — a spread of ~80 cents (~2.1%). This is a deal arb, not a Druckenmiller-style concentrated thesis on earnings inflection or macro tailwind. The key criteria I look for — accelerating earnings direction driving price discovery, a forward catalyst the market hasn't priced, asymmetric upside with a defined invalidation — are all absent or inverted here. The upside is capped at $38.50 (deal price), and the downside if the deal breaks is meaningful (stock was ~$29-30 pre-deal based on 52-week low of $21.71 and the ~27% surge). The asymmetry is therefore NEGATIVE: ~2% gain if deal closes, potentially 15-25% loss if it breaks. That is the opposite of what I want. On standalone fundamentals, the business is genuinely inflecting — net new ARR of $14M (best in 7 quarters), subscription net retention at 102%, FCF of $149M, GAAP operating margin hitting record highs, and a usage-based pricing model pilot with 'overwhelmingly positive' early feedback. Management targets Rule of 40 by FY28. These are real signals of an earnings cycle turning up. But all of that is now irrelevant — the tape has collapsed into a narrow arb band. Price action at the 52-week high ($37.70-37.92) is deceptive; it's ceiling-capped by the deal, not freely confirming a breakout. There is no 'why now' catalyst for a long: if you believe the deal closes, you earn 2%; if you're betting on a bump (to $40+), you need a competing bidder which there is no evidence of. The law firm investigation is routine and not signal. Liquidity/Fed tailwind: not a primary driver here — the deal dynamics overwhelm any macro read. The standalone DCF shows ~31% upside to $49.52 intrinsic value, but that is now irrelevant until/unless the deal breaks, at which point the stock reprices lower before that value can be captured. I cannot size up on a 2% arb spread with negative asymmetry — that violates every principle of concentrated, asymmetric positioning.

Key points

Acquisition by Publicis at $38.50/share announced May 2026; stock at $37.70 = ~2.1% arb spread, capping upside
Standalone earnings inflection is real — best net new ARR in 7 quarters, FCF $149M, GAAP margins at record — but irrelevant while deal is pending
Asymmetry is inverted: ~2% gain if deal closes vs. ~15-25% loss if deal breaks (stock was pre-deal ~$29-30)
No directional thesis possible: price is ceiling-capped by $38.50 deal, not freely trading on earnings trajectory
Usage-based pricing pilot and FY28 Rule of 40 target represent genuine forward earnings catalysts — but only relevant as standalone, post-break scenario
Deal risk flags present: regulatory/shareholder approval pending, termination fee ~$32M, law firm investigating merger fairness (routine but adds noise)

Red flags

Negative asymmetry: max upside ~$0.80/share, downside potentially $5-10+/share on deal break — cannot size concentratedly
No 'why now' catalyst: thesis is either 'deal closes at $38.50' (2% return) or speculative bump bid (no evidence)
Price action tells you nothing useful — stock is frozen in arb band, not confirming a directional breakout
Standalone DCF at $49.52 only matters if deal fails, at which point you'd buy cheaper post-repricing
Tape has effectively terminated as a signal — merger arb dynamics override all technical and fundamental reads
Management commentary on standalone performance is now historical artifact; real-time forward visibility is zero until deal outcome

Seth Klarman — 🔴 avoid · 28/100 · high confidence

LiveRamp is no longer a standalone investment opportunity — it is a pending acquisition arbitrage trading at $37.70 against a hard $38.50 cash offer from Publicis. The spread of ~$0.80/share (2.1%) represents the entire available return, and the Klarman value framework does not qualify M&A arbitrage at a 2% spread as offering any margin of safety. Viewed as a standalone business prior to the deal, the fundamentals are interesting but not cheap enough: revenue CAGR of ~11%, FCF of $149M, P/FCF of ~15x, P/S of 2.8x. The DCF base-case intrinsic value is $49.52, suggesting 31% upside to that estimate — but the stock is now capped at $38.50 by the deal price. The DCF itself is heavily back-loaded (73% terminal value) and assumes revenue CAGR as the FCF growth proxy, which is optimistic. On a conservative, stress-tested basis — say, 6-8% FCF growth and a higher WACC — intrinsic value compresses significantly. The balance sheet is clean: $396M cash, modest liabilities, current ratio 2.7x, net cash position — but this provides no discount opportunity at current price. Pre-deal, a value investor might have found RAMP interesting in the $22-28 range (near the 52-week low of $21.71), where true margin of safety existed. At $37.70, capital is nearly fully committed to the deal closing at $38.50 — yielding 2.1% with deal-failure risk that could send shares back to $25-30 (a 20-30% loss). This is an asymmetric bet the wrong way: tiny upside, meaningful downside if deal breaks. No margin of safety. The correct Klarman posture is to hold cash and wait for a better opportunity.

Key points

Acquisition at $38.50/share confirmed by Publicis; stock at $37.70 implies 2.1% spread — not a value investment, it's M&A arb at a negligible return
Clean balance sheet ($396M cash, net cash position, current ratio 2.7x) is genuinely positive but irrelevant at current deal-implied price
FCF of $149M and P/FCF of 15.4x is not expensive for the business quality, but the deal price hard-caps the upside — no room for value to compound
Pre-deal DCF suggests $49.52 intrinsic value, but 73% of that is terminal value — highly sensitive to assumptions and not a conservative anchor
Subscription revenue growth of mid-single digits and ROIC of only 5.4% suggest the moat is narrower than the narrative implies
Usage-based pricing pilot and AI partnerships are speculative optionality — not hard, asset-backed value that Klarman would underwrite
Revenue CAGR of 10.9% applied as FCF growth to DCF is optimistic; conservative stress test (6% growth, higher WACC) yields sub-$38 intrinsic value
The only 'catalyst' now is deal close — but at 2% spread, risk/reward is deeply unfavorable for a value investor

Red flags

Deal-failure scenario: regulatory delay or termination could reset stock to $25-30 range, representing 20-30% permanent capital loss — worst case far exceeds best case gain of 2.1%
No margin of safety at current price — the stock is priced at the deal, not at a discount to intrinsic value
73% of DCF value is terminal value — exactly the type of growth-dependent, optimism-reliant valuation that Klarman avoids underwriting
ROIC of 5.4% is below WACC of 10.1% — capital is not being efficiently compounded; suggests the business is not a genuine value compounder
History of net losses 2021-2024 ($34M, $119M loss, $12M profit, $1M loss) before the FY2025 profit spike — earnings quality and sustainability require scrutiny
Law firm investigation into merger fairness introduces litigation risk and potential deal delay; routine but not zero risk
Platform migration gross margin drag 'taking longer than expected' — a classic sign of execution risk that could impair FCF if deal breaks and company trades standalone
Opex structure and SBC (while declining 23% YoY) remains a source of dilution risk in a deal-failed scenario

Walter Schloss — 🔴 avoid · 22/100 · high confidence

LiveRamp fails the Schloss deep-value test on virtually every criterion I care about. The stock is trading at $37.70, which is essentially at its 52-week HIGH (not low), and is within 80 cents of the announced Publicis acquisition price of $38.50. This is the precise opposite of a beaten-down, out-of-favor bargain. Price-to-book is 2.38x — well above tangible book, and that book value itself is almost certainly inflated by intangibles and goodwill from prior acquisitions. This is an asset-light SaaS/data connectivity business; the hard assets are negligible (capex of only $1.4M, mostly software). Tangible book is likely a fraction of stated equity of $962M given the technology-heavy balance sheet. The thesis now is entirely merger arbitrage — collecting the $0.80 spread between $37.70 and the $38.50 deal price — which is emphatically NOT what I do. I buy hard-asset bargains and wait years; I don't play deal spreads. The long-term debt situation is somewhat ambiguous in the data ($254M reported for a 2015 period, current data shows minimal net debt of -$141M suggesting net cash), and the current ratio of 2.72 is healthy, but none of that matters when the price is at a peak and the story is a growth/AI/data narrative rather than tangible asset value. Earnings history is volatile — losses in FY2021, FY2022, FY2024, with a big profit spike in FY2025 ($146M net income) that may include one-time items. Revenue CAGR of ~11% is fine but irrelevant to my method. SBC dilution has been a persistent concern in tech names like this. No dividend. Insider ownership not meaningfully disclosed in the available data, and the Form 4 shows RSU withholding (tax sales), not purchases. The DCF shows $49.52 intrinsic value, but that model is built on growth assumptions and terminal value (73% of value sits in terminal value) — exactly the kind of forecast-dependent valuation I distrust. This name belongs to a growth investor or M&A arbitrageur, not a Schloss-style asset bargain hunter.

Key points

Stock at 52-week HIGH ($37.70) and near acquisition price of $38.50 — opposite of a Schloss beaten-down bargain
Price-to-book of 2.38x on a book value dominated by intangibles/software assets; tangible book likely far lower
Asset-light business model: $1.4M capex, no meaningful hard assets to anchor downside protection
Investment case is now pure M&A arbitrage ($0.80 spread to $38.50 deal) — not my method
Balance sheet has net cash (~$141M net), current ratio 2.72x — the one Schloss-friendly feature, but overwhelmed by all negatives
No dividend; SBC historically dilutive in tech names; insider activity shows RSU tax withholding, not buying
Net income volatile: losses in FY21, FY22, FY24; FY25 profit of $146M may include non-recurring items

Red flags

Trading at 52-week high, not a multi-year low — Schloss required price depression, not price peaks
High price-to-book (2.38x) with likely minimal tangible book value given intangible-heavy tech balance sheet
Thesis depends entirely on growth narratives (AI, commerce media, usage-based pricing) and DCF projections, not hard assets
73% of DCF value sits in speculative terminal value — exactly the kind of forecast dependence I avoid
Deal arbitrage situation: risk/reward of $0.80 upside vs. deal break risk is not a Schloss margin of safety
Persistent SBC dilution historically; no dividend; no meaningful insider ownership stake identified
Acquisition overhang creates business disruption risk (talent loss, customer uncertainty) that clouds standalone asset value

Fact base appendix

Price

last_close: 37.7
as_of: 2026-06-28
high_52w: 37.7
low_52w: 37.7
pct_below_52w_high: 0.0

Fundamentals

last_price: 37.7
market_cap: 2291644128
fifty_two_week_high: 37.92
fifty_two_week_low: 21.71
beta: 1.2752386
currency: USD
exchange: NEW YORK STOCK EXCHANGE, INC.
sector: Technology
industry: Technology
price_source: finnhub
bars: 1
entity: LiveRamp Holdings, Inc.
fiscal_year: 2025
revenue: 812940000
revenue_period: 2026-03-31
net_income: 146000000
net_income_period: 2026-03-31
operating_income: 83466000
operating_income_period: 2026-03-31
operating_cash_flow: 150132000
operating_cash_flow_period: 2013-03-31
capex: 1376000
capex_period: 2026-03-31
total_assets: 1269173000
total_assets_period: 2025-12-31
total_liabilities: 142079000
total_liabilities_period: 2019-03-31
current_assets: 679309000
current_assets_period: 2025-12-31
current_liabilities: 250000000
current_liabilities_period: 2025-12-31
stockholders_equity: 962270000
stockholders_equity_period: 2025-12-31
cash_and_equivalents: 395888000
cash_and_equivalents_period: 2025-12-31
long_term_debt: 254539000
long_term_debt_period: 2015-03-31
shares_outstanding: 60087866
operating_margin: 0.1027
net_margin: 0.1796
roe: 0.1517
debt_to_equity: 0.2645
current_ratio: 2.7172
roic: 0.0542
free_cash_flow: 148756000
fcf_margin: 0.183
pe_ratio: 15.7
price_to_fcf: 15.41
price_to_sales: 2.82
revenue_cagr: 0.1087
revenue_cagr_years: 3
fundamentals_source: edgar_companyfacts
price_to_book: 2.38
earnings_yield: 0.0388
peg: 1.44

Filings reviewed

10-K (2026-05-21) https://www.sec.gov/Archives/edgar/data/733269/000073326926000025/ramp-20260331.htm
8-K (2026-05-18) https://www.sec.gov/Archives/edgar/data/733269/000110465926062908/tm2614904d1_8k.htm
8-K (2026-03-19) https://www.sec.gov/Archives/edgar/data/733269/000110465926032070/tm269390d1_8k.htm
10-Q (2026-02-05) https://www.sec.gov/Archives/edgar/data/733269/000073326926000012/ramp-20251231.htm
10-Q (2025-11-05) https://www.sec.gov/Archives/edgar/data/733269/000073326925000057/ramp-20250930.htm
10-K (2025-05-21) https://www.sec.gov/Archives/edgar/data/733269/000073326925000030/ramp-20250331.htm

Other sources

[news] LiveRamp (NYSE: RAMP) to be Acquired at $38.50 per Share; $M Cash Deal - Stock Titan
[news] Form 4 Liveramp Holdings Inc For: 23 June By Investing.com - Investing.com Canada
[news] LiveRamp (NYSE: RAMP) CRO has 1,232 shares withheld to cover RSU taxes - Stock Titan
[news] Liveramp Holdings Inc (RAMP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
[news] Adobe and LiveRamp tie purchase data to AI ads for commerce networks - Stock Titan
[news] Publicis Acquires LiveRamp for $2.2B as RAMP Stock Surges 27% on Announcement - TIKR.com
[news] We Think LiveRamp Holdings' (NYSE:RAMP) Robust Earnings Are Conservative - Yahoo Finance
[news] Johnson Fistel Investigates Proposed and Potential - GlobeNewswire
[news] Liveramp Holdings Inc (RAMP) Valuation: PE, PB & Fair Value Analysis - TradingKey
[news] InvestingPro Fair Value nails 68% return on LiveRamp stock By Investing.com - Investing.com
[news] LiveRamp jumps after earnings beat and $2.5 billion Publicis takeover deal (RAMP) - Yahoo Finance
[news] LiveRamp Holdings, Inc. Actuals & Estimates (NYSE:RAMP) - TradingView
[news] Liveramp Holdings Inc (RAMP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
[news] RAMP Forecast — Price Target — Prediction for 2027 - TradingView
[news] LiveRamp Holdings (RAMP) Stock Could Be 40% Undervalued As AI Marketing Demand Grows - Sahm
[discussion] @Corporateport30 it’ll either be the biggest false hope or biggest comeback story ever. A buyout at
[discussion] $RAMP Brilliant piece that captures RAMP's situation perfectly. So if you want to update your un
[discussion] $RUM RUMBLE IS BUILDING A SPATIOTEMPORAL AI DATA ENGINE

WHEN YOU KNOW WHAT PEOPLE WATCH, WHERE TH

[discussion] $RAMP - LiveRamp Holdings Inc - 10K - Updated Risk Factors

RAMP’s new risks center on its pending

[discussion] $RAMP will never understand this stupid arbitrage concept . This is a %100 confirmed deal . Who, why
[discussion] $BRZE prime target for M&A after announcement of $RAMP buyout.
[discussion] late night recap (May 18) $D +9.41% biggest utility merger in us history $NEE -4.63% acquirer pays
[discussion] LiveRamp Holdings, Inc. ( $RAMP ) SpicyTrade - Daily Stock Analysis https://youtu.be/mCOFezTWzO0?si=
[discussion] 19 #stockbreakouts $CD (base), $D (gap), $RAMP (gap), $SCBFY, $TOYO. Two sub-$1, two $1-2
[discussion] $RAMP LiveRamp Stock Surges 27% on Fourth Quarter Beat and Publicis Acquisition Deal

https://mark

[discussion] $RAMP Sold all, very good gain, thanks RAMP
[discussion] [Bullish] $GOVX $2.65 next leg up. $3.00 —> $3.50

Lots of covering will take place final hour. A

[discussion] $RAMP got bought by Publicis for €2.2B and the stock is +27% sitting near 52w highs, which is the le
[discussion] Top Gainers PT2

$CREG $CISS $H

[discussion] Top Gainers PT2

$CMND $HIVE $CREG $AIM $RAMP

[earnings_call] LiveRamp Holdings, Inc RAMP Q2 2026 Earnings Call

Generated 2026-07-17T20:43:04 · est. cost $1.45

What each investor thinks

AI & Disruption Referee (Christensen-style) Referee

pass · 72

Forensic Short-Seller (Chanos/Einhorn-style) Referee

pass · 62

Valuation Referee (Damodaran-style) Referee

watch · 58

Bruce Greenwald Value

watch · 58

Terry Smith (Fundsmith) Quality

watch · 58

Michael Mauboussin Quality

watch · 58

Chuck Akre Quality

watch · 55

Joel Greenblatt Value

watch · 55

Warren Buffett Quality

watch · 52

Ray Dalio Risk

watch · 52

Philip Fisher Growth

watch · 52

Peter Lynch Growth

watch · 52

Howard Marks Risk

watch · 52

Charlie Munger Quality

watch · 52

Benjamin Graham Value

watch · 48

Stanley Druckenmiller Risk

avoid · 28

Seth Klarman Value

avoid · 28

Walter Schloss Value

avoid · 22

Want this on a name you own?Send a ticker; we convene the full council on it.

Request Analysis →